Novo Nordisk

organization NVO

Last mentioned: Mar 19, 2026

Timeline

Mar 19, 2026
Pitt Breakthrough

Researchers reveal a new approach to bypass leptin resistance at the molecular level.
2023
GLP-1 Dominance

Drugs like Wegovy and Zepbound revolutionize the obesity market.
1995
Clinical Failures

Early leptin trials fail due to the discovery of leptin resistance in obesity.
1994
Discovery of Leptin

Jeffrey Friedman identifies the hormone as a key regulator of body weight.

Stories mentioning Novo Nordisk 1

Pitt Researchers Unveil Novel Leptin-Based Obesity Treatment Strategy

University of Pittsburgh researchers have identified a new mechanism to overcome leptin resistance, a major hurdle in obesity treatment. This approach aims to restore the brain's sensitivity to satiety signals, potentially offering a sustainable alternative to current GLP-1 therapies.

Mar 19, 2026 6 sources